Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New market launch for novel anticonvulsant: Topamax available in Germany

Dec. 22, 1998

SmithKline Beecham patents combined 5-HT1A/5-HT1B/5-HT1D receptor antagonists

Dec. 22, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

First evidence that citicoline favorably affects human brain lipid metabolism

Dec. 21, 1998

EP1 receptor antagonists described by Ono for pain, fever and diuresis

Dec. 21, 1998

Allelix treatment for dementia enters phase I trials

Dec. 21, 1998

FDA approves Treatment IND for Orphan Medical's Xyrem oral solution

Dec. 21, 1998

U.K. launch for novel antipsychotic agent: zotepine

Dec. 18, 1998

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...